Resveratrol Protects C6 Astrocyte Cell Line against Hydrogen Peroxide-Induced Oxidative Stress through Heme Oxygenase 1

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Quincozes Santos, André ^a   Bobermin, Larissa Daniele ^a   Latini, Alexandra ^b   Wajner, Moacir ^a   Souza, Diogo Onofre ^a   Gonçalves, Carlos Alberto ^a   Gottfried, Carmem ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CREATINE KINASE; GLUTATHIONE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; RESVERATROL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; BIOCHEMISTRY; CELL LINEAGE; CELL PROTECTION; CELL STRAIN; CELL STRAIN C6; CELL STRESS; CHEMICAL PARAMETERS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROCHEMISTRY; NEUROTOXICITY; NITROSATIVE STRESS; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ASTROCYTES; CELL LINE; GLUTATHIONE; HEME OXYGENASE-1; HUMANS; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877770709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064372     Document Type: Article

References (96)

1. Fremont L, (2000) Biological effects of resveratrol. Life Sci 66: 663-673.
2. Soleas GJ, Diamandis EP, Goldberg DM, (1997) Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30: 91-113.
3. Pervaiz S, (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17: 1975-1985.
4. Delmas D, Jannin B, Latruffe N, (2005) Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res 49: 377-395.
5. de la Lastra CA, Villegas I, (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35: 1156-1160.
6. Baur JA, Sinclair DA, (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
7. Bastianetto S, Quirion R, (2010) Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp Neurol 225: 237-239.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
9. Pervaiz S, (2004) Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat 7: 333-344.
10. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, et al. (2009) Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297: H1876-1881.
11. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
12. Virgili M, Contestabile A, (2000) Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett 281: 123-126.
13. Sinha K, Chaudhary G, Gupta YK, (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71: 655-665.
14. Quincozes-Santos A, Gottfried C, (2011) Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann N Y Acad Sci 1215: 72-78.
15. Richard T, Pawlus AD, Iglesias ML, Pedrot E, Waffo-Teguo P, et al. (2011) Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci 1215: 103-108.
16. Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL, (2011) Resveratrol protects rats from Abeta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 6: e29102.
17. Quincozes-Santos A, Nardin P, de Souza DF, Gelain DP, Moreira JC, et al. (2009) The janus face of resveratrol in astroglial cells. Neurotox Res 16: 30-41.
18. Vieira de Almeida LM, Pineiro CC, Leite MC, Brolese G, Leal RB, et al. (2008) Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochem Res 33: 8-15.
19. de Almeida LM, Leite MC, Thomazi AP, Battu C, Nardin P, et al. (2008) Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Arch Biochem Biophys 480: 27-32.
20. Fukui M, Choi HJ, Zhu BT, (2010) Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 49: 800-813.
21. Tiwari V, Chopra K, (2011) Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem 117: 678-690.
22. Lee EO, Park HJ, Kang JL, Kim HS, Chong YH, (2010) Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1/2 pathway in rat hippocampal slice cultures. J Neurochem 112: 1477-1487.
23. Dringen R, Kussmaul L, Hamprecht B, (1998) Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Res Brain Res Protoc 2: 223-228.
24. Dringen R, Pawlowski PG, Hirrlinger J, (2005) Peroxide detoxification by brain cells. J Neurosci Res 79: 157-165.
25. Forman HJ, (2007) Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic Biol Med 42: 926-932.
26. Droge W, (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
27. Halliwell B, (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97: 1634-1658.
28. Dore S, (2005) Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity. Neurosignals 14: 61-70.
29. Scapagnini G, Butterfield DA, Colombrita C, Sultana R, Pascale A, et al. (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6: 811-818.
30. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Dore S, (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224: 325-329.
31. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW (2010) When NRF2 Talks, Who's Listening? Antioxid Redox Signal.
32. Moncada S, Bolanos JP, (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-1689.
33. Coyle JT, Puttfarcken P, (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
34. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, et al. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8: 766-775.
35. Halliwell B, (2007) Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res 73: 341-347.
36. Sun AY, Wang Q, Simonyi A, Sun GY, (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41: 375-383.
37. Markiewicz I, Lukomska B, (2006) The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol Exp (Wars) 66: 343-358.
38. Maragakis NJ, Rothstein JD, (2006) Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2: 679-689.
39. Belanger M, Allaman I, Magistretti PJ, (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14: 724-738.
40. Nedergaard M, Ransom B, Goldman SA, (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26: 523-530.
41. Quincozes-Santos A, Andreazza AC, Goncalves CA, Gottfried C, (2010) Actions of redox-active compound resveratrol under hydrogen peroxide insult in C6 astroglial cells. Toxicol In Vitro 24: 916-920.
42. dos Santos AQ, Nardin P, Funchal C, de Almeida LM, Jacques-Silva MC, et al. (2006) Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 453: 161-167.
43. Hu J, Castets F, Guevara JL, Van Eldik LJ, (1996) S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271: 2543-2547.
44. Lissi E, Salim-Hanna M, Pascual C, del Castillo MD, (1995) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18: 153-158.
45. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, et al. (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260: 406-417.
46. Klamt F, Shacter E, (2005) Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage. J Biol Chem 280: 21346-21352.
47. Hughes BP, (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7: 597-603.
48. Aebi H, (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
49. Wendel A, (1981) Glutathione peroxidase. Methods Enzymol 77: 325-333.
50. Browne RW, Armstrong D, (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108: 347-352.
51. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
52. Jou MJ, (2008) Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv Drug Deliv Rev 60: 1512-1526.
53. Leone S, Fiore M, Lauro MG, Pino S, Cornetta T, et al. (2008) Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells. Mol Carcinog 47: 587-598.
54. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, et al. (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958: 439-447.
55. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P, (2008) Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci 9Suppl 2: S6.
56. Halliwell B, (2009) The wanderings of a free radical. Free Radic Biol Med 46: 531-542.
57. Gao HM, Zhou H, Hong JS, (2012) NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci 33: 295-303.
58. Quincozes-Santos A, Andreazza AC, Nardin P, Funchal C, Goncalves CA, et al. (2007) Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 28: 886-891.
59. Moncada S, Palmer RM, Higgs EA, (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
60. Hattori R, Otani H, Maulik N, Das DK, (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 282: H1988-1995.
61. Kim JW, Lim SC, Lee MY, Lee JW, Oh WK, et al. (2010) Inhibition of neointimal formation by trans-resveratrol: role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction. Mol Nutr Food Res 54: 1497-1505.
62. Arredondo F, Echeverry C, Abin-Carriquiry JA, Blasina F, Antunez K, et al. (2010) After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 49: 738-747.
63. Li MH, Jang JH, Na HK, Cha YN, Surh YJ, (2007) Carbon monoxide produced by heme oxygenase-1 in response to nitrosative stress induces expression of glutamate-cysteine ligase in PC12 cells via activation of phosphatidylinositol 3-kinase and Nrf2 signaling. J Biol Chem 282: 28577-28586.
64. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, et al. (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33: 2444-2471.
65. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, et al. (2008) Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L478-488.
66. Erlank H, Elmann A, Kohen R, Kanner J, (2011) Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones. Free Radic Biol Med 51: 2319-2327.
67. Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, et al. (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11: 497-508.
68. Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, et al. (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 1147: 61-69.
69. Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA, (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28: 13574-13581.
70. Vargas MR, Johnson JA, (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 11: e17.
71. Murias M, Jager W, Handler N, Erker T, Horvath Z, et al. (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 69: 903-912.
72. Halliwell B, (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716.
73. Latini A, Borba Rosa R, Scussiato K, Llesuy S, Bello-Klein A, et al. (2002) 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res 956: 367-373.
74. Halliwell B, (2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 141: 312-322.
75. Gutteridge JM, Halliwell B, (2010) Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun 393: 561-564.
76. Ovesna Z, Horvathova-Kozics K, (2005) Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 52: 450-455.
77. Bai G, Rama Rao KV, Murthy CR, Panickar KS, Jayakumar AR, et al. (2001) Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 66: 981-991.
78. Choi IY, Lee SJ, Ju C, Nam W, Kim HC, et al. (2000) Protection by a manganese porphyrin of endogenous peroxynitrite-induced death of glial cells via inhibition of mitochondrial transmembrane potential decrease. Glia 31: 155-164.
79. Beal MF, (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23: 298-304.
80. Pope SA, Milton R, Heales SJ, (2008) Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem Res 33: 1410-1418.
81. Spanier G, Xu H, Xia N, Tobias S, Deng S, et al. (2009) Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60Suppl 4: 111-116.
82. Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, et al. (2008) Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 45: 1178-1189.
83. Sebai H, Sani M, Yacoubi MT, Aouani E, Ghanem-Boughanmi N, et al. (2010) Resveratrol, a red wine polyphenol, attenuates lipopolysaccharide-induced oxidative stress in rat liver. Ecotoxicol Environ Saf 73: 1078-1083.
84. Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, et al. (2007) Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 80: 1033-1039.
85. Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, et al. (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 1328: 139-151.
86. Meng Q, Velalar CN, Ruan R, (2008) Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic Biol Med 44: 1032-1041.
87. Dringen R, (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671.
88. Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, et al. (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24: 2533-2545.
89. Escartin C, Won SJ, Malgorn C, Auregan G, Berman AE, et al. (2011) Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression. J Neurosci 31: 7392-7401.
90. Vargas MR, Pehar M, Cassina P, Beckman JS, Barbeito L, (2006) Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem 97: 687-696.
91. Shen HM, Pervaiz S, (2006) TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20: 1589-1598.
92. Hamby ME, Gragnolati AR, Hewett SJ, Hewett JA, (2008) TGF beta 1 and TNF alpha potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2. Neurochem Int 52: 962-971.
93. Vang O, Ahmad N, Baile CA, Baur JA, Brown K, et al. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 6: e19881.
94. Kwon KJ, Kim JN, Kim MK, Lee J, Ignarro LJ, et al. (2011) Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res 50: 110-123.
95. Bobermin LD, Quincozes-Santos A, Guerra MC, Leite MC, Souza DO, et al. (2012) Resveratrol prevents ammonia toxicity in astroglial cells. PLoS One 7: e52164.
96. Yun JM, Chien A, Jialal I, Devaraj S, (2012) Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem 23: 699-705.